抗菌薬耐性の緊急の課題をウプサラ抗生物質センターの専門家の洞察とともに探ります。ホストのエヴァ・ガルメンディアとエリン・フェルメルと一緒に、魅力的なディスカッションに参加してください。
Ep 61: Elias Arnér, redox & EbsArgent. Ceftazidime-avibactam for P. aeruginosa treatment. FusB-mediated resistance.
68 mins • May 12, 2025
Charts
This show is not currently ranked in any charts.
最近のエピソード
May 12, 2025
Ep 61: Elias Arnér, redox & EbsArgent. Ceftazidime-avibactam for P. aeruginosa treatment. FusB-mediated resistance.
68 mins
Apr 7, 2025
Ep 60: Till Bachmann & providing solutions for AMR. AI to help tackle AMR. Horizontal gene transfer drivers.
68 mins
Mar 3, 2025
Ep 59: Vance Fowler & the Antibacterial Resistance Leadership Group. Pipeline for studying AMR in pig farms. Commentary on public involvement.
56 mins
Feb 3, 2025
Ep 58: Evangelos Mourkas, campylobacter & urbanization. Probiotics & AMR. Plasmid-chromosome cross-talk.
65 mins
Dec 3, 2024
Ep 57: Olivier Rubin & AMR governance. November update. Rifaximin & daptomycin cross-resistance.
69 mins
